Skip to main content

Advertisement

Log in

Aloperine suppresses LPS-induced macrophage activation through inhibiting the TLR4/NF-κB pathway

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

The currently available anti-inflammatory drugs often cause diverse side effects with long-term use. Exploring anti-inflammatory drugs with better efficacy and lower toxicity presents an ongoing challenge. Aloperine is an alkaloid extracted from the leaves and seeds of Sophora alopecuroides L. However, the anti-inflammatory effects of Aloperine have not been fully elucidated. This study aimed to investigate whether Aloperine suppresses lipopolysaccharide (LPS)-induced inflammatory responses in RAW264.7 macrophages.

Methods

RAW264.7 macrophages were stimulated with LPS (1 μg/mL) in the presence or absence of Aloperine (50 and 100 μM). mRNA expression was measured by real-time PCR, and protein expression was assessed by western blot analysis. The secretion of pro-inflammatory cytokines was measured by ELISA. The levels of nitric oxide (NO) and reactive oxygen species (ROS) were measured by staining. The transcriptional activity of NF-κB was assayed by a luciferase activity assay.

Results

The results proved that Aloperine inhibited the expression of LPS-induced pro-inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-17A (IL-17A)] in macrophages. Treatment with Aloperine inhibited NO production through suppressing inducible nitric oxide synthase (iNOS) expression and the secretion of prostaglandin E2 (PGE2) by inhibiting cyclooxygenase 2 (COX-2) expression. Aloperine prevented LPS-induced oxidative stress by reducing the generation of ROS. Furthermore, aloperine significantly reduced Toll-like receptor 4 (TLR4) and myeloid differentiation factor (Myd-88) levels and prevented the nuclear translocation of nuclear factor-κB (NF-κB) in LPS-treated macrophages.

Conclusion

Taken together, our findings show that Aloperine could suppress LPS-induced macrophage activation by inhibiting the TLR4/Myd-88/NF-κB pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Gordon S, Taylor P. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953–64.

    Article  CAS  Google Scholar 

  2. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest. 2007;117:89–93.

    Article  CAS  Google Scholar 

  3. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol. 1996;60:8–26.

    Article  CAS  Google Scholar 

  4. Wu C, Zhao W, Zhang X, Chen X. Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathways. Acta Pharm Sin B. 2015; 5(4):323–329.

    Article  Google Scholar 

  5. Yang L, Guo H, Li Y, Meng X, Yan L, Zhang D, Wu S, Zhou H, Peng L, Xie Q, et al. Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways. Sci Rep. 2016;6:34611.

    Article  CAS  Google Scholar 

  6. Jeong YH, Oh YC, Cho WK, Yim NH, Ma JY. Anti-inflammatory effect of rhapontici radix ethanol extract via inhibition of NF-κB and MAPK and induction of HO-1 in macrophages. Mediat Inflam. 2016;2016:7216912.

    Google Scholar 

  7. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.

    Article  CAS  Google Scholar 

  8. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986–1000.

    Article  CAS  Google Scholar 

  9. Shin JS, Hong Y, Lee HH, Ryu B, Cho YW, Kim NJ, Jang DS, Lee KT. Fulgidic Acid isolated from the rhizomes of cyperus rotundus suppresses LPS-Induced iNOS, COX-2, TNF-α, and IL-6 expression by AP-1 inactivation in RAW264.7 macrophages. Biol Pharm Bull. 2015;38(7):1081–1086.

  10. Jiang WY, Jeon BH, Kim YC, Lee SH, Sohn DH, Seo GS. PF2401-SF, standardized fraction of Salvia miltiorrhiza shows anti-inflammatory activity in macrophages and acute arthritis in vivo. Int Immunopharmacol. 2013;16(2):160–164.

    Article  CAS  Google Scholar 

  11. Li Fan SY, Zhang SL. Antiviral effect of aloperine. J Zhong Cao Yao. 1998;29:253–4.

    Google Scholar 

  12. Zhou CC, Gao HB, Sun XB, Shi HB, Liu W, Yuan HN, et al. Anti-inflammatory and anti-allergic action of aloperine. Zhongguo Yao Li Xue Bao. 1989;10:360–5.

    CAS  PubMed  Google Scholar 

  13. Ren D, Ma W, Guo B, Wang S. Aloperine attenuates hydrogen peroxide-induced injury via anti-apoptotic activity and suppression of the nuclear factor-κB signaling.

  14. Wu C, Zhao W, Zhang X, Chen X. Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathways. Acta Pharm Sin B. 2015; 5(4):323–329.

    Article  Google Scholar 

  15. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K. Cyclooxygenase 2:a pharmacological target for the prevention for cancer. Lancet Oncol. 2001; 2(9):544.

  16. Watkins DN, Peroni DJ, Lenzo JC, et al. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur Respir J. 1999;13(5):999–1007.

    Article  CAS  Google Scholar 

  17. Cao Y, Prescott SM. Many actions of cyclooxyrgenase 2 in cellular dynamics and in cancer. J Cell Physiol. 2002;190(3):279–86.

    Article  CAS  Google Scholar 

  18. Totsuka N, Kim YG, Kanemaru K, Niizuma K, Umemoto E, Nagai K, Tahara-Hanaoka S, Nakahasi-Oda C, Honda S, Miyasaka M, et al. Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration. Nat Commun. 2014;5:4710.

    Article  CAS  Google Scholar 

  19. Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 2013;48(1):190–204.

    Article  CAS  Google Scholar 

  20. Shao J, Li Y, Wang Z, Xiao M, Yin P, Lu Y et al. Novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted- inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol. 2013; 17(2):216–228.

    Article  CAS  Google Scholar 

  21. Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, Yamoah K, et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 2007;26(21):4457–66.

    Article  CAS  Google Scholar 

  22. Lin S, Wu H, Wang C, Xiao Z, Xu F. Regulatory T cells and acute lung injury: cytokines, uncontrolled inflammation, and therapeutic implications. Front Immunol. 2018;9:1545.

    Article  Google Scholar 

  23. Fujiwara Y, Takeya M, Komohara Y. A novel strategy for inducing theantitumor effects of triterpenoid compounds: blocking the protumoralfunctions of tumor-associated macrophages via STAT3 inhibition. Biomed Res Int. 2014;2014:348539.

    PubMed  PubMed Central  Google Scholar 

  24. Lee HT, Kim SK, Kim SH, Kim K, Lim CH, Park J, Roh TY, Kim N, Chai YG. Transcription-related element gene expression pattern differs between microglia and macrophages during inflammation. Inflamm Res. 2014;63(5):389–97.

    Article  CAS  Google Scholar 

  25. Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–40.

    Article  CAS  Google Scholar 

  26. Cen X, Liu S, Cheng K. The role of toll-like receptor in inflammation and tumor immunity. Front Pharmacol. 2018;9:878.

    Article  Google Scholar 

  27. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55–61.

    Article  CAS  Google Scholar 

  28. Zhang G, Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through toll-like receptors. J Endotoxin Res. 2000;6(6):453–7.

    Article  CAS  Google Scholar 

  29. Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, Dong W. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965.

    PubMed  PubMed Central  Google Scholar 

  30. Wardyn JD, Ponsford AH, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans. 2015;43:621–6.

    Article  CAS  Google Scholar 

  31. Wang C, Choi YH, Xian Z, Zheng M, Piao H, Yan G. Aloperine suppresses allergic airway inflammation through NF-κB, MAPK, and Nrf2/HO-1 signaling pathways in mice. Int Immunopharmacol. 2018;65:571–9.

    Article  CAS  Google Scholar 

  32. Leon CG, Tory R, Jia J, Sivak O, Wasan KM. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res. 2008;25(8):1751–61.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Key research fund of wannan medical college (WK2018ZF05).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yinyin Ye or Liangfei Tao.

Ethics declarations

Conflict of interest

None.

Additional information

Responsible Editor: John Di Battista.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, Y., Wang, Y., Yang, Y. et al. Aloperine suppresses LPS-induced macrophage activation through inhibiting the TLR4/NF-κB pathway. Inflamm. Res. 69, 375–383 (2020). https://doi.org/10.1007/s00011-019-01313-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-019-01313-0

Keywords

Navigation